To Evaluate the Impact of MRSA Nasal Screen Implementation. | NCT07748143

NCT07748143

Overview

NCT ID: NCT07748143
Lead Sponsor: Methodist Health SystemOTHER
Official Title: The Effect of MRSA Nasal Screen Implementation on Duration of Therapy and Cost Associated With Vancomycin Use.
Brief Summary: To evaluate the impact of MRSA nasal screen implementation on duration of therapy and cost associated with vancomycin use.
Conditions: MRSA
Interventions: Duration of therapy
Direct Cost
Pharmacokinectic Monitoring
Hospital stay

Status and Timeline

Status: Completed
Last Update Posted: Aug 5, 2026Actual
Start Date: Oct 1, 2019Actual
Primary Completion Date: Jun 1, 2026Actual
Completion Date

Participation Criteria

Ages Eligible for Study: Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: No
Eligibility Criteria: Inclusion Criteria:

Age > 18 years

Diagnosis of pneumonia

Admission inpatient to Methodist Richardson Medical Center

Treatment with vancomycin empirically

Exclusion Criteria:

Age ≤ 18 years

Patients with other confirmed gram positive infections

Study Plan

Study Type: Observational
Phase: No data available
Enrollment: 21Actual
Primary Purpose: No data available
Allocation: No data available
Interventional Model: No data available
Masking

Contacts and Locations

Central Contacts: No data available
Locations: Methodist Dallas Medical Center- Clinical Research Institute

Similar Studies

Participant Group/Arms

The direct cost of vancomycin

The direct cost of vancomycin for each patient will then be calculated. An average duration of therapy and the average cost of therapy per patient will be calculated.

Other: Duration of therapy

Other: Direct Cost

Other: Pharmacokinectic Monitoring

Other: Hospital stay

NCT00302120Unknown status

The MONET - Study: MR Mammography of Nonpalpable Breast Tumors

NCT03749993Completed

Evaluation of a MRI-based Prostate Cancer Screening Program

NCT02091518Enrolling by invitation

Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis Methods

NCT06666387Completed

The New Combined PET-MR System NextGen PET-MR With Syngo MR XA80A: Evaluation of Diagnostic Image Quality and Usability (Software and Hardware) in the Clinical Setting.

NCT00490503Completed

Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

NCT01428739Completed

Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

NCT03568448Active, not recruiting

Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

NCT03458455Unknown status

Improved Therapy Response Assessment in Metastatic Brain Tumors